SG11202113046PA - Affinity agents - Google Patents

Affinity agents

Info

Publication number
SG11202113046PA
SG11202113046PA SG11202113046PA SG11202113046PA SG11202113046PA SG 11202113046P A SG11202113046P A SG 11202113046PA SG 11202113046P A SG11202113046P A SG 11202113046PA SG 11202113046P A SG11202113046P A SG 11202113046PA SG 11202113046P A SG11202113046P A SG 11202113046PA
Authority
SG
Singapore
Prior art keywords
affinity agents
affinity
agents
Prior art date
Application number
SG11202113046PA
Other languages
English (en)
Inventor
William Scott Dodson
Brandon Kier
Brandon Coyle
Sarah Valentini
Thomas Scanlon
Warren Kett
Original Assignee
Avitide LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avitide LLC filed Critical Avitide LLC
Publication of SG11202113046PA publication Critical patent/SG11202113046PA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/075—Adenoviridae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202113046PA 2019-05-24 2020-05-22 Affinity agents SG11202113046PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962852717P 2019-05-24 2019-05-24
US201962949878P 2019-12-18 2019-12-18
PCT/US2020/034340 WO2020242988A2 (en) 2019-05-24 2020-05-22 Affinity agents

Publications (1)

Publication Number Publication Date
SG11202113046PA true SG11202113046PA (en) 2021-12-30

Family

ID=73552041

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202113046PA SG11202113046PA (en) 2019-05-24 2020-05-22 Affinity agents

Country Status (12)

Country Link
US (1) US20220213447A1 (ja)
EP (1) EP3977128A4 (ja)
JP (2) JP2022533278A (ja)
KR (1) KR20220029571A (ja)
CN (1) CN114207438A (ja)
AU (1) AU2020283748A1 (ja)
BR (1) BR112021023540A2 (ja)
CA (1) CA3138355A1 (ja)
IL (1) IL288299A (ja)
MX (1) MX2021014334A (ja)
SG (1) SG11202113046PA (ja)
WO (1) WO2020242988A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022192597A2 (en) * 2021-03-10 2022-09-15 Avitide, Inc. Affinity agents
WO2023122327A2 (en) * 2021-12-24 2023-06-29 Avitide LLC Chi domain affinity ligands and agents
CN114196638B (zh) * 2021-12-28 2023-12-15 武汉美博尔津生物科技有限公司 一种腺相关病毒纯化试剂盒及纯化方法
WO2023196892A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091565A1 (en) * 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
WO2008124015A1 (en) * 2007-04-09 2008-10-16 The Regents Of The University Of California Methods for purifying adeno-associated virus virions
WO2011119484A1 (en) * 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
WO2013063379A1 (en) * 2011-10-28 2013-05-02 University Of North Carolina At Chapel Hill Cell line for production of adeno-associated virus
WO2014078734A2 (en) * 2012-11-15 2014-05-22 Apellis Pharmaceuticals, Inc. Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
JP6871232B2 (ja) * 2015-04-06 2021-05-12 サブドメイン リミテッド ライアビリティ カンパニー 新規結合ドメイン含有ポリペプチドおよびその使用
CN108137651B (zh) * 2015-10-23 2022-02-22 富士胶片株式会社 环肽、亲和层析载体、标记抗体、抗体药物复合物及药物制剂
EP3442985B1 (en) * 2016-04-16 2024-06-05 University of Florida Research Foundation, Incorporated Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus

Also Published As

Publication number Publication date
JP2022533278A (ja) 2022-07-21
WO2020242988A2 (en) 2020-12-03
JP2023078401A (ja) 2023-06-06
WO2020242988A3 (en) 2021-01-07
US20220213447A1 (en) 2022-07-07
AU2020283748A1 (en) 2022-02-03
BR112021023540A2 (pt) 2022-03-22
EP3977128A2 (en) 2022-04-06
KR20220029571A (ko) 2022-03-08
MX2021014334A (es) 2022-02-21
IL288299A (en) 2022-01-01
EP3977128A4 (en) 2023-10-18
CN114207438A (zh) 2022-03-18
CA3138355A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
CA191995S (en) Travel kit
CA196372S (en) Soundbar
CA189498S (en) Showerbase
SG11202113046PA (en) Affinity agents
GB201814169D0 (en) Blockchain autonoumous agents
CA191618S (en) Floorwasher - nozzle
CA201154S (en) Banquette
CA190552S (en) Hand-dryer
CA189795S (en) Handshower
CA189677S (en) Uroflowmeter
GB201913756D0 (en) Contrast agent
GB201912107D0 (en) Combination
CA193248S (en) Mandoline
EP4071294C0 (en) CORD WINDING IRON
GB2594907B (en) Composition comprising anti-acanthamoeba agents
CA190385S (en) Beverageware
CA190384S (en) Beverageware
CA189047S (en) Hammock-tent
CA194482S (en) Kick-scooter
GB202017642D0 (en) Therapeputic agents
GB201908318D0 (en) Anti-parasitic agents
GB201917017D0 (en) Lipa
DK3832828T3 (en) Strømforyningsnetsystem
CA192228S (en) Hydrogenerator
CA190974S (en) Hoodie